SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050920
Filing Date
2018-08-09
Accepted
2018-08-09 15:17:58
Documents
71
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14100_110q.htm 10-Q 1230354
2 EX-31.1 a18-14100_1ex31d1.htm EX-31.1 13169
3 EX-31.2 a18-14100_1ex31d2.htm EX-31.2 13276
4 EX-32.1 a18-14100_1ex32d1.htm EX-32.1 7216
5 EX-32.2 a18-14100_1ex32d2.htm EX-32.2 7237
  Complete submission text file 0001104659-18-050920.txt   6577223

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20180630.xml EX-101.INS 1573835
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20180630.xsd EX-101.SCH 50142
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20180630_cal.xml EX-101.CAL 72347
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20180630_def.xml EX-101.DEF 176709
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20180630_lab.xml EX-101.LAB 497264
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20180630_pre.xml EX-101.PRE 336320
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 181004722
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences